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The AP-1 and AP-2 complexes are the most abundant
adaptors in clathrin-coated vesicles (CCVs), but clathrin-
mediated trafficking can still occur in the absence of any
detectable AP-1 or AP-2. To find out whether adaptor
abundance reflects cargo abundance, we used lectin pull-
downs to identify the major membrane glycoproteins in
CCVs from human placenta and rat liver. Both prepara-
tions contained three prominent high molecular-weight
proteins: the cation-independent mannose 6-phosphate
receptor (CIMPR), carboxypeptidase D (CPD) and low-
density lipoprotein receptor-related protein 1 (LRP1). To
investigate how these proteins are sorted, we con-
structed and stably transfected CD8 chimeras into HeLa
cells. CD8-CIMPR localized mainly to early/tubular
endosomes, CD8-CPD to the trans Golgi network and
CD8-LRP1 to late/multivesicular endosomes. All three
constructs redistributed to the plasma membrane when
clathrin was depleted by siRNA. CD8-CIMPR was also
strongly affected by AP-2 depletion. CD8-CPD was mod-
erately affected by AP-2 depletion but strongly affected
by depleting AP-1 and AP-2 together. CD8-LRP1 was only
slightly affected by AP-2 depletion; however, mutating
an NPXY motif in the LRP1 tail caused it to become AP-
2 dependent. These results indicate that all three pro-
teins have AP-dependent sorting signals, which may
help to explain the relative abundance of AP complexes
in CCVs. However, the relatively low abundance of cargo
proteins in CCV preparations suggests either that some
of the APs may be empty or that the preparations may be
dominated by empty coats.
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Cargo proteins are sorted and packaged into clathrin-
coated vesicles (CCVs) by interacting with adaptors,
which bind to specific sorting signals in the cytoplasmic
tails of the cargo proteins and link them to clathrin. There
are two highly abundant adaptors in mammalian CCVs:
AP-1 (for adaptor protein complex 1), which is involved in
clathrin-mediated intracellular trafficking, and AP-2, which
is involved in clathrin-mediated endocytosis. Both AP-1
and AP-2 are heterotetramers, consisting of two large
subunits (g and b1 in AP-1, a and b2 in AP-2), a medium-
sized (m) subunit and a small (s) subunit (1,2). The m sub-
units bind to sorting signals with the consensus sequence
YXXF (3,4), and the g-type large subunits together with
the s subunits bind to sorting signals with the consensus
sequence [D/E]XXXL[L/I] (5). Clathrin-coated vesicle pre-
parations from different tissues contain different ratios of
AP-1 to AP-2 (e.g. in mammary gland, there is more AP-1,
whereas in brain there is more AP-2) (6), but invariably, the
AP complexes are major components of the CCVs, sec-
ond in abundance only to clathrin itself.
Over the last 2 years, others and we have been investigat-
ing the functions of the AP-1 and AP-2 complexes in tissue
culture cells using siRNA knockdowns. Surprisingly, we
have found that even when we deplete AP-2 to undetect-
able levels, some cargo proteins are still endocytosed
normally in a clathrin-dependent manner. Thus, the trans-
ferrin receptor, which has a YXXF-sorting signal, and a
chimeric construct containing a [D/E]XXXL[L/I]-sorting sig-
nal, are both strongly affected by AP-2 knockdown (7,8).
However, a low-density lipoprotein (LDL) receptor chimera
(CD8-LDLR), which has an NPXY sorting signal, and the
EGF receptor, which may use ubiquitin as a sorting signal
(9; see also 10,11), are still internalized at normal rates in
AP-2-depleted cells. On the basis of these observations,
we proposed that proteins with YXXF and [D/E]XXXL[L/I]
signals need AP-2 for their internalization, but that other
proteins, including the LDL and EGF receptors, may make
use of alternative endocytic adaptors, such as Dab2 and
epsin, which bind to NPXY and ubiquitin, respectively (7).
Although less is known about the AP-1 pathway, we have
found that CCVs isolated from AP-1-depleted cells still
contain cargo proteins that traffic between intracellular
membranes, indicating that there are also alternative adap-
tors for intracellular trafficking (12).
If some cargo proteins do not need APs to be packaged
into CCVs, why then do CCVs contain so much more AP-1
and AP-2 than any of the other adaptors? One possibility is
that the CCVs also contain much more AP-dependent
cargo than AP-independent cargo. So far, the only study
to address the question of cargo abundance is a recent
proteomics analysis of rat brain CCVs by McPherson and
co-workers (13). They found that the majority of the cargo
proteins in their preparations were synaptic vesicle com-
ponents, which had presumably been captured by the
CCVs during membrane retrieval after neurotransmitter
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release. However, most of these proteins are expressed
only in neurons and neuroendocrine cells, and so far, very
little is known about their sorting signals.
To investigate how more representative cargo proteins are
sorted, we have isolated CCVs from human placenta and
rat liver and used lectin pulldowns to identify the most
abundant membrane glycoproteins. We have then trans-
planted the cytoplasmic tails of these proteins onto a CD8
reporter and stably transfected the constructs into HeLa
cells, so that we could follow their trafficking in control
and siRNA-treated cells.
Results
Major membrane glycoproteins in CCVs from
placenta and liver
Clathrin-coated vesicles were isolated from human pla-
centa and rat liver, and their purity was monitored using
electron microscopy (EM) and SDS–PAGE followed by
mass spectrometry. Both preparations were found to con-
sist mainly of coated structures (Figure 1A), including
some coats that clearly contain vesicles (arrows) as well
as smaller coats that may be empty. By SDS–PAGE, we
found clathrin and AP subunits to be the major gel bands
in both preparations (Figure 1B). However, there are clear
differences in the protein composition of the two prepara-
tions. Visual inspection of some of the bands identified
using mass spectrometry indicates that the AP-2 complex
is more abundant in placenta CCVs, while in liver CCVs
there is more AP-1 (e.g. note the relative intensities of the
m1 and m2 subunits in the two lanes).
None of the major gel bands in either preparation corre-
sponded to CCV cargo proteins. To enrich for such pro-
teins, we took advantage of the observation that most of
the CCV cargo proteins that have been identified, including
cell surface receptors and lysosomal membrane proteins,
are glycosylated. Thus, we extracted the preparations with
1 M Tris – HCl and 1% Triton-X-100, to solubilize coat and
membrane proteins, respectively, then pulled down glyco-
proteins using lectin affinity matrices. We tried a number
of different lectins (see Materials and Methods) and found
that wheat germ agglutinin (WGA), which binds N-acetyl-
glucosamine and sialic acid, gave the most clear-cut
results. Concanavalin A, which binds mannose, produced
a similar pattern by SDS–PAGE (unpublished observa-
tions), indicating that the WGA pulldown enriches for all
glycoproteins that contain N-acetylglucosamine and/or sia-
lic acid and not just those that are particularly rich in those
two sugars. Figure 1C shows a WGA pulldown from
human placenta CCVs, next to a crude membrane fraction
from an earlier stage in the preparation, which was treated
in an identical manner. The CCV lane has a much simpler
pattern, with several prominent bands. The bands labeled
1–5 were excised and analyzed using mass spectrometry.
The three high molecular-weight bands, 1, 2 and 3, were
found to be LDL receptor-related protein 1 (LRP1), the
cation-independent mannose 6-phosphate receptor
(CIMPR) and carboxypeptidase D (CPD), respectively.
Band 4 contained several proteins, including the EGF
receptor and oxytocinase, which is the human placental
ortholog of the insulin-regulated aminopeptidase found in
rat adipocytes. Band 5 was matched with the transferrin
receptor. All of these are proteins that cycle between
endosomes, the plasma membrane and/or the trans
Golgi network (TGN), so their enrichment in CCVs is con-
sistent with what is known about their intracellular traffick-
ing. However, we could not have predicted that these
would be the most abundant proteins in the lectin pull-
downs (e.g. the LDL receptor, which was the first CCV
cargo protein to be characterized, was not detectable in
the pulldowns, whereas CPD has never before been
shown to be associated with clathrin).
To find out whether CCVs from liver also contain these
glycoproteins, we carried out a similar pulldown using a
Tris/Triton extract of a rat liver preparation. Again, we
found three high molecular-weight bands, which by mass
spectrometry were shown to be LRP1, CIMPR and CPD
(Figure 1D). Thus, even though placenta and liver carry out
different functions and differ in their relative abundance of
AP-1 and AP-2, their CCVs are dominated by the same
three major cargo glycoproteins.
Localization of CD8 chimeras
LRP1, CIMPR and CPD are all type I membrane proteins,
and there is evidence that most or all of the targeting
information for the three proteins resides in their cyto-
plasmic tails (14–18). Therefore, we were able to investi-
gate their sorting in HeLa cells using a CD8 chimera
system. Figure 2 shows the three constructs diagramma-
tically, together with the sequences of their cytoplasmic
tails. Known or suspected sorting signals for clathrin-
mediated trafficking are indicated in the sequences in
bold. All three chimeras were transfected into HeLa cells
using an IRES vector, and stably expressing cell lines were
cloned.
The steady-state distribution of the constructs is shown in
Figure 3A–F. Unlike wild-type CD8, which is localized
mainly at the plasma membrane in transfected HeLa
cells (19, and our own unpublished observations), all
three of the chimeras have a predominantly intracellular
distribution. However, each of the constructs has a dis-
tinct localization pattern. Double labeling for various mar-
ker proteins showed that much of the CIMPR chimera
(Figure 3A) is endosomal, co-localizing with internalized
WGA, especially at early time points (Figure 3B shows
WGA internalized for 15 min). There is also a more peri-
nuclear pool of CD8-CIMPR, which is likely to reside in the
TGN (16). The CPD chimera (Figure 3C) has near-perfect
co-localization with TGN46 (Figure 3D). The LRP1 chimera
(Figure 3E), like the CIMPR chimera, localizes to
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endosomes, but it shows better overlap with internalized
EGF than with internalized WGA, especially at later time
points (Figure 3F shows EGF internalized for 30 min). This
indicates that the LRP1 chimera resides in a later endoso-
mal compartment than the CIMPR chimera.
To examine the localization of the three chimeras at the
ultrastructural level, we labeled frozen thin sections of the
cells with anti-CD8 followed by protein A coupled to
15 nm gold. CD8-CIMPR was found to be associated
with tubulovesicular membranes scattered throughout
the cell (Figure 4A). CD8-CPD also had a tubular appear-
ance, but with a much more restricted distribution, nearly
always positioned on one side of a Golgi stack (Figure 4B).
CD8-LRP1 had the lowest density of labeling, but some of
the multivesicular bodies were positive for this construct,
both on the limiting membrane and on internal vesicles
(Figure 4C). Thus, the EM localization data are consistent
with the immunofluorescence results and confirm that
CD8-CIMPR is associated with early (tubular) endosomes,






























































Figure 1: Micrographs and gels
of clathrin-coated vesicles (CCVs)
purified from human placenta
and rat liver. A) CCVs were nega-
tively stained and examined by
electron microscopy. Both prepara-
tions appear to be purified to near
homogeneity. Some of the coats
that clearly contain vesicles are
indicated with arrows. Scale bar:
200 nm; B) SDS–PAGE of the
two preparations. Each lane con-
tains approximately 3.5 mg protein.
Gel bands were identified using
mass spectrometry. CHC: clathrin
heavy chain; CLCs: clathrin light
chains. C) and D) Crude mem-
branes or CCVs (containing 350 mg
protein) were extracted with 1 M
Tris–HCl and 1% Triton-X-100,
and glycoproteins were pulled
down using a wheat germ aggluti-
nin (WGA) affinity matrix and
analyzed using mass spectrometry.
The indicated bands correspond to
low-density lipoprotein receptor-
related protein 1 (LRP1) (band 1),
the cation-independent mannose
6-phosphate receptor (CIMPR)
(band 2), carboxypeptidase D
(CPD) (band 3), the EGF receptor
and oxytocinase (band 4) and the
transferrin receptor (band 5). Each
lane contains half of the total elu-
ate; thus, approximately 50 times
the amount of CCV protein shown
in (B) was used to produce each of
the two CCV pulldown lanes.
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CD8-CPD with the TGN and CD8-LRP1 with later (multi-
vesicular) endosomes.
Enrichment of the chimeras in CCVs
Although all three chimeras accumulate in compartments
that can be accessed by clathrin-mediated trafficking, we
did not see much co-localization with clathrin at either the
light or the electron microscope level. However, the asso-
ciation of cargo proteins with CCVs is known to be very
transient, so that at any one time most of the protein will
be elsewhere in the cell. To investigate whether the three
constructs are getting packaged into CCVs, we isolated
CCVs from each of the cell lines. We have previously
shown that CCV preparations from HeLa cells are less
clean than preparations from tissues like placenta or
liver, so we have developed a control for specificity (12).
Cells are depleted of clathrin heavy chain using siRNA,
then a CCV preparation is carried out in the usual manner.
Preparations from the clathrin-depleted cells still contain
all of the contaminants found in control preparations, such
as ribosomes and smooth membrane vesicles, but they
are devoid of CCVs. By comparing the levels of a particular
protein in preparations from control and clathrin-depleted
cells, we can determine whether or not it is a bona fide
CCV component.
Figure 5 shows equal protein loadings of homogenates


















Figure 2: Diagram of the CD8 con-
structs and sequences of their
cytoplasmic tails. Potential cla-
thrin-dependent sorting signals are
indicated in bold. The tyrosine in the
lipoprotein receptor-related protein 1
(LRP1) tail that contributes both to
the second NPXY motif and to the

















Endocytosed WGA TGN46 Endocytosed EGF
Figure 3: Steady-state distribu-
tion of the three chimeras. CD8-
CIMPR (A) shows significant
co-localization with wheat germ
agglutinin endocytosed for
15 min (B). CD8-CPD (C) strongly
co-localizes with TGN 46 (D). CD8-
LRP1 (E) shows partial co-localiza-
tion with EGF endocytosed for
30 min (F) (some of the areas of
overlap are indicated with arrows).
Scale bar: 10 mm.
Sorting of Cargo Proteins into CCVs
Traffic 2005; 6: 1014–1026 1017
cell lines and from a CD8-expressing cell line, probed with
antibodies against CD8, clathrin heavy chain and (as a
loading control) EF-2, a ribosome-associated protein. In
the cells expressing CD8 on its own, it is clear that the
construct is not enriched in CCVs. In fact, there is less
CD8 in the CCV preparation than in the whole cell homo-
genate and slightly more CD8 in the CCV preparation
when clathrin is depleted. This indicates that the CD8 is
not actually in the CCVs but in contaminating membranes.
In contrast, both the CIMPR chimera and the CPD chimera
are strongly enriched in the CCV preparation over whole
cell homogenate, and in both cases, most of the signal is
lost from the CCV preparation when the cells are depleted
of clathrin. The blot of the LRP1 chimera is somewhat
harder to interpret because of the relatively low expres-
sion of the construct, which goes up dramatically when
clathrin is knocked down (compare the signals in the
homogenates of control and clathrin-depleted cells).
Leupeptin also causes a dramatic increase in the expres-
sion of the LRP1 chimera (unpublished observations), indi-
cating that much of the construct may be trafficking to
lysosomes and getting degraded and that this pathway
may be impaired when clathrin is depleted. Although simi-
lar amounts of CD8-LRP1 are present in the CCV prepara-
tions from control and clathrin-depleted cells, this is not a
fair comparison because there is more LRP1 chimera to
start with in the clathrin-depleted cells. A better compar-
ison can be made between the homogenate and CCV
lanes of the control cells and between the homogenate
and CCV lanes of the clathrin-depleted cells. Here, it can
be seen that the LRP1 chimera is strongly enriched in the
CCV preparation from the control cells but not in the
preparation from the clathrin-depleted cells. Thus, all
three of the chimeras, but not CD8 alone, are packaged
as cargo into CCVs.
Surface expression of the chimeras
If the three chimeras are being internalized by clathrin-
mediated endocytosis, then knocking down clathrin
should cause them to accumulate on the cell surface,
and if the internalization is AP-2 dependent, then knocking
down AP-2 should have a similar effect. Therefore, we
treated each of the three cell lines with siRNAs, then
quantified the amount of construct on the cell surface by
incubating the cells at 4 C with anti-CD8 followed by 125I-
protein A.
Figure 6A shows the total amount of label bound to the
cells under control conditions and after either AP-2 (m2) or
clathrin knockdown. There is a great deal of variability in
surface labeling in the untreated cells: a significant amount
of both the CIMPR and the CPD chimera is at the plasma
membrane, while the signal from the cells expressing the
LRP1 chimera is only approximately twofold the signal we
get when we label control HeLa cells, which do not
express any CD8. In Figure 6B, we have normalized the
results by dividing the signal after knockdown by the
signal before knockdown. Knocking down AP-2 causes
the amount of CD8-CIMPR at the cell surface to go up
approximately threefold, and knocking down clathrin pro-
duces approximately fourfold increase. Knocking down
AP-2 also causes approximately threefold increase in the
amount of CD8-CPD at the cell surface, while knocking
down clathrin produces approximately 15-fold increase.
The CD8-LRP1-expressing cells are the least affected by
AP-2 knockdown, with only approximately 40% increase
in the amount of construct at the cell surface, but they are
the most strongly affected by clathrin knockdown, with
approximately 25-fold increase. Thus, although all three
constructs are affected to some extent by both clathrin








Figure 4: Localization of the three chimeras using electron
microscopy. Frozen thin sections were labeled with anti-CD8
followed by protein A coupled to 15 nm gold. A) The
CD8-CIMPR chimera localizes to tubulovesicular membranes. B)
The CD8-CPD chimera is highly concentrated in TGN membranes.
C) The CD8-LRP1 chimera localizes to multivesicular bodies, both
the limiting membrane and the internal vesicles. Scale bar:
200 nm.
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The CD8-CIMPR chimera
The increase in the surface expression of the various
chimeras after clathrin knockdown is not necessarily
caused by a block in clathrin-mediated endocytosis; it
could also be due to a disruption in clathrin-mediated
intracellular trafficking. For instance, the CIMPR has
sorting signals in its cytoplasmic tail that bind to AP-1
and Golgi-localized g-ear-containg, ARF-binding proteins
(GGAs), both of which are involved in trafficking between
the TGN and endosomes, and abolishing these pathways
could cause the CD8-CIMPR construct to accumulate on
the cell surface. To look specifically at endocytosis of the
CIMPR chimera, we used an antibody uptake assay that
we developed for our previous studies on the CD8-LDLR
chimera (7).
Cells were incubated with anti-CD8 followed by 125I-pro-
tein A at 4 C, then warmed to 37 C for various lengths of
time, after which the protein A remaining on the cell sur-
face was removed by acid stripping. Figure 7A shows the
percentage of prebound label that has been internalized,
averaging results from three separate experiments carried
out on different days. The rate of uptake of antibody in the
untreated cells and the decrease in antibody uptake in the
clathrin-depleted cells are virtually identical to what we
found in our earlier study on the LDLR chimera (7).
However, whereas knocking down AP-2 has no effect on
the rate of internalization of CD8-LDLR, it has nearly as
strong an effect on the rate of internalization of CD8-
CIMPR as knocking down clathrin. Thus, this experiment
provides further evidence that AP-2 is required for efficient
endocytosis of the CD8-CIMPR chimera.
The CD8-CPD chimera
We used the same antibody uptake assay to monitor the
rate of internalization of the CD8-CPD chimera in control
and siRNA-treated cells. Figure 7B shows that in control
cells, the construct is taken up efficiently, although not
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Figure 5: Enrichment of the constructs in clathrin-coated vesicles. Equal protein loadings of whole cell homogenates and CCV
preparations from control (con) and clathrin-depleted (kDa) cells were analyzed using SDS–PAGE followed by Western blotting. EF-2, a
ribosome-associated protein, was used as a loading control. CD8 is not enriched in CCVs over whole cell homogenate, and it is not
lost from the CCV preparation when clathrin is depleted. CD8-CIMPR and CD8-CPD are both strongly enriched in the CCV preparation, and
the signal is greatly reduced in preparations from clathrin-depleted cells. CD8-LRP1 is also enriched in the CCV preparation when
compared with whole cell homogenate, although the increased stability of the construct in clathrin-depleted cells means that the



























Figure 6: Surface expression of CD8 chimeras in control and
siRNA-treated cells. A) Cells were incubated at 4 C with anti-
CD8 followed by 125I-protein A, and total counts per minute per
mg cell protein (CPM) were plotted. B) Surface expression was
normalized for each of the cell lines by dividing the CPM in the
siRNA-treated cells by the CPM in the control cells. Both clathrin
and AP-2 knockdowns increase the surface expression of all three
chimeras, but the relative effects are very different.
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quite as rapidly as the CIMPR chimera. Knocking down
clathrin strongly inhibits the internalization of the construct
at early time points, and knocking down AP-2 also has a
strong inhibitory effect. However, for reasons that are not
clear, at later time points (e.g. 30 min) there is much more
uptake of the CPD chimera than of the CIMPR chimera in
clathrin- and AP-2-depleted cells. Nevertheless, the results
clearly show that the CPD chimera requires both clathrin
and AP-2 for rapid and efficient internalization.
Because clathrin depletion causes approximately 15-fold
increase in the amount of CD8-CPD at the cell surface,
while AP-2 depletion only causes approximately threefold
increase (see Figure 6), it is likely that clathrin is involved
in the trafficking of the construct not only at the plasma
membrane but also at intracellular locations. The presence
of an acidic cluster in the cytoplasmic tail of CPD suggests
that its trafficking may be dependent on phosphofurin
acidic cluster sorting protein 1 (PACS-1) (20). PACS-1
was originally identified in a yeast two-hybrid library
screen as a binding partner for furin, another acidic clus-
ter-containing protein that resides mainly in the TGN.
PACS-1 is believed to provide a link between acidic clus-
ter-containing cargo proteins and AP-1, allowing the cargo
proteins to be retrieved from endosomes and recycled
back to the TGN in a clathrin-dependent manner (21).
Therefore, we used two new siRNAs to deplete PACS-1
and a previously characterized siRNA to deplete AP-1,
then quantified the amount of CD8-CPD at the cell sur-
face. Figure 8A shows that both of the PACS-1 siRNAs are
effective at depleting their target protein.
In the AP-1-depleted cells, there is approximately sixfold
increase in surface labeling for CD8-CPD (Figure 8B). This
is consistent with AP-1 contributing to clathrin-mediated
sorting of CPD. Surprisingly however, knocking down
PACS-1 has no effect, suggesting either that the acidic
cluster is not the dominant sorting signal or alternatively
that the acidic cluster does not need PACS-1 for its sorting.
We also investigated the effect of knocking down AP-1 and
AP-2 together. Interestingly, like the clathrin knockdown,
the combined knockdown causes approximately 15-fold
increase in the amount of CD8-CPD at the cell surface.
These results indicate that AP-1 and AP-2 act synergistic-
ally to maintain the steady-state distribution of CPD, with
AP-1 facilitating packaging into intracellular CCVs and AP-2
facilitating packaging into endocytic CCVs.
Because there may be changes in the intracellular distri-
bution of CD8-CPD that do not lead to changes in the
amount on the cell surface, we also used immunofluores-
cence to compare the steady-state localization of the chi-
mera in cells treated with the various siRNAs. Figure 9
shows that knocking down either clathrin, AP-1 or AP-1
and AP-2 together causes the construct to move away
from the TGN into a more peripheral location. However,
knocking down AP-2 does not have a very strong effect on
the intracellular distribution of CD8-CPD, and PACS-1-
depleted cells are not noticeably different from controls.
The CD8-LRP1 chimera
LRP1 is a receptor for a number of different extracellular
ligands (22), so it was surprising that there was so little of
the chimera on the cell surface. This could be either
because the construct normally appears only briefly at
the plasma membrane and then is rapidly internalized or
alternatively because it rarely arrives at the plasma mem-
brane. We initially attempted to investigate the endocyto-
sis of the LRP1 chimera using the same 4 C binding,
37 C warm-up assay that we used for the CIMPR and




































Figure 7: Internalization kinetics of the CIMPR and CPD chi-
meras. Control and siRNA-treated cells expressing either CD8-
CIMPR (A) or CD8-CPD (B) were incubated at 4 C with anti-CD8
followed by 125I-protein A, then warmed to 37 C for various
lengths of time, after which label remaining on the cell surface
was removed by acid stripping. The graph shows the percentage
of total counts that are still cell-associated. Both clathrin and AP-2
depletion strongly affect the rate of uptake of both constructs.
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difficult to get meaningful data. Therefore, we developed a
simple, FACS-based assay for internalization.
Cells were incubated with Cy5-conjugated anti-CD8 either
at 4 C, to allow surface binding but not internalization, or
at 37 C, to allow both binding and internalization, then
trypsinized and analyzed by flow cytometry. Figure 10A
shows representative histograms of control HeLa cells,
CD8-expressing cells and CD8-LRP1-expressing cells.
The control HeLa cells bind only a very small amount of
antibody at 4 C (solid gray), which does not increase if the
incubation is done at 37 C (black line). The CD8-expres-
sing cells bind approximately 500-fold more antibody than
the control HeLa cells, but the fluorescence intensity at
the two temperatures is similar; indeed, there is slightly
more antibody bound at 4 C. In the CD8-LRP1-expressing
cells, although there is only about twice as much fluores-
cence at 4 C as in the control cells, the signal goes up a
further twofold when the cells are incubated at 37 C,
indicating that construct is trafficking to the cell surface,
binding antibody and trafficking inside again during the
time course of the experiment.
We next investigated the effects of knocking down either
AP-2 or clathrin on the fluorescence of the CD8-LRP1-
expressing cells at the two temperatures. Figure 10B
shows that AP-2 depletion does not affect the 37:4 ratio,
indicating that endocytosis of the construct still proceeds
normally in the absence of AP-2. However, when clathrin is
depleted the fluorescence intensity is the same at 37 and
4 C, indicating that endocytosis of the construct is
impaired. Thus, as predicted by the antibody-binding assay
(Figure 6), clathrin depletion prevents the chimera from
being internalized, but AP-2 depletion has little or no effect.
The cytoplasmic tail of LRP1 contains a number of poten-
tial clathrin-dependent sorting signals, both AP-2 depen-
dent and AP-2 independent: NPTY, DVGGLL, NPVY, YATL
and EKRELL (see Figure 2). Of the two NPXY-type motifs,
only the second is preceded by a phenylalanine in the 2
position, and there is evidence that [F/Y]XNPXY is the
optimal motif for internalization (9,23). This sequence
overlaps with the YATL motif, with the same tyrosine
contributing to both. Therefore, we mutated this tyrosine
to an alanine, expecting to see a strong effect on the
trafficking and/or steady-state distribution of the
construct.
Surprisingly, the mutant construct has the same apparent
steady-state distribution as the wild-type construct
(Figure 11A; see also Figure 3), showing partial overlap
with internalized EGF (Figure 11B). Knocking down cla-
thrin increases the surface expression of the mutant con-
struct >30-fold (Figure 11C), which is similar to the effect
of clathrin knockdown on the wild-type construct (see
Figure 6). However, unlike the wild-type construct, the
surface expression of the mutant construct is also strongly
affected by AP-2 knockdown (Figure 11C; see also
Figure 6). We also used the flow cytometry assay to
monitor endocytosis of the construct and found approxi-
mately twofold increase in fluorescence intensity when
control cells were incubated at 37 C, which was abol-
ished by clathrin knockdown (Figure 11D). This again is
similar to our data on cells expressing the wild-type con-
struct (see Figure 10B). However, AP-2 knockdown is
nearly as effective as clathrin knockdown in blocking the
internalization of the mutant construct. These results sug-
gest that the FXNPXY motif is the dominant sorting signal
in the chimera with the wild-type LRP1 tail, and that when
it is abolished, another sorting signal(s) – presumably one





































































Surface expression of CD8-CPD
Figure 8: Surface expression of CD8-CPD in control and
siRNA-treated cells. A) The effectiveness of the two PACS-1
siRNAs was tested by Western blotting. Although the antibody
cross-reacts with other proteins, the band with the expected size
for PACS-1 (arrow) disappears when cells are treated with either
of the two siRNAs. B) Cells were incubated at 4 C with anti-CD8
followed by 125I-protein A, and surface expression was normal-
ized by dividing the CPM in the siRNA-treated cells by the CPM in
the control cells. AP-2 depletion causes approximately threefold
increase in surface expression, clathrin depletion causes approxi-
mately 15-fold increase, AP-1 depletion causes approximately
sixfold increase and depletion of both AP-1 and AP-2 causes
approximately 15-fold increase. However, neither of the PACS-1
siRNAs causes a significant increase in surface expression of
CD8-CPD.
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Control AP-2 kd Clathrin kd
AP-1 kd PACS-1 kd AP-1+AP-2 kd
CD8-CPD: steady-state distribution
Figure 9: Steady-state distribution
of CD8-CPD in control and siRNA-
treated cells. Knocking down clathrin
and AP-1 (either alone or in combina-
tion with AP-2) causes the construct to
move away from the TGN into more
peripheral membranes. Knocking
down AP-2 on its own has at most a
weak effect, and knocking down
PACS-1 has no discernible effect.
































Figure 10: Endocytosis of CD8-
LRP1 determined by flow cyto-
metry. A) Cells were incubated
with Cy5-conjugated anti-CD8 at
either 4 or 37 C, and the signal
was quantified by flow cytometry.
Representative histograms of
control (i.e. nontransfected), CD8-
expressing and CD8-LRP1-expres-
sing cells are shown. The increase
in signal at 37 C in the CD8-LRP1-
expressing cells indicates that the
chimera is trafficking to the cell sur-
face and getting internalized. B)
Data pooled from three experi-
ments on untreated and siRNA-
treated CD8-LRP1-expressing cells
using the assay shown in (A). There
is approximately twofold increase in
signal at 37 C in both untreated
and AP-2-depleted cells, indicating
that AP-2 depletion does not inhibit
internalization of the chimera. In the
clathrin-depleted cells, the signal is
the same at the two temperatures,
indicating that internalization is
blocked.
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Discussion
A number of different sorting signals have been identified
for clathrin-mediated trafficking (9), only two of which, the
YXXF motif and the [D/E]XXXL[L/I] motif, have been defi-
nitively shown to bind to AP complexes. The other motifs
may function by binding to other adaptors, such as Dab2
and epsin at the plasma membrane, and GGAs and epsinR
on intracellular membranes. However, at least in mamma-
lian CCVs, there is much more AP-1 and AP-2 than any of
the other adaptors. This led us to speculate that the major
cargo proteins in CCVs might depend upon AP complexes
for their sorting.
Although many cargo proteins have been shown to be
enriched in CCVs by Western blotting, so far, little is
known about the relative amounts of these proteins and
how they are packaged. To identify the major membrane
glycoproteins in CCVs, we carried out WGA pulldowns on
extracts of CCVs purified from human placenta and rat
liver. In both cases, we found three prominent high mol-
ecular-weight bands: CIMPR, CPD and LRP1. The trans-
ferrin receptor, which is probably the best-characterized
CCV cargo protein, was also visible as a Coomassie Blue-
stained band in the human placenta pulldown. Because
CIMPR, CPD and LRP1 are all type I membrane proteins,
we were able to transplant their cytoplasmic tails onto a
CD8 reporter and investigate the sorting of all three con-
structs using antibodies against CD8. In addition to carry-
ing out immunolocalization and surface-binding assays,
we have made use of a new method we recently devel-
oped, which involves isolating CCVs from control and
siRNA-treated cells (12). We find that all three constructs
are highly enriched in CCVs from control cells but not from
clathrin-depleted cells, demonstrating that this method























CD8-LRP1(NPVA) Endocytosed EGF 
CD8-LRP1(NPVA)









Figure 11: Steady-state distribu-
tion and behavior of a CD8-LRP1
chimera with a mutation in the
NPVY motif. A) and B) Cells were
stably transfected with a construct in
which the tyrosine had been mutated
to an alanine [CD8-LRP1(NPVA)]. The
construct (A) still shows partial
co-localization with EGF internalized
for 30 min (B) (some of the areas of
overlap are indicated with the
arrows). Scale bar: 10 mm; C) The sur-
face expression of CD8-LRP1 (NPVA)
was determined by incubating cells at
4 C with anti-CD8 followed by 125I-
protein A and normalized by dividing
the CPM in the siRNA-treated cells by
the CPM in the control cells. Both
clathrin and AP-2 depletion strongly
increase the surface expression of
the NPVA mutant. D) Internalization
of CD8-LRP1 (NPVA) was assayed
by incubating cells with Cy5-conju-
gated anti-CD8 at either 4 or 37 C
and quantifying the signal using flow
cytometry. Both clathrin and AP-2
depletion decrease the signal at
37 C relative to 4 C, indicating that
both knockdowns inhibit internaliza-
tion of the NPVA mutant.
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endogenous cargo proteins but also of engineered pro-
teins that have been transfected into the cells.
Of the three CCV cargo proteins, the CIMPR has been the
most extensively studied, and our results are largely in
agreement with previous findings. The CD8-CIMPR chi-
mera, like endogenous CIMPR, localizes primarily to endo-
somes and the TGN, and is efficiently packaged into
CCVs. There is also a substantial amount of the construct
at the plasma membrane, and perhaps as a consequence,
clathrin knockdowns have a less dramatic effect on the
surface expression of CD8-CIMPR than either CD8-CPD or
CD8-LRP1, causing only a fourfold increase. AP-2 knock-
downs also cause an increase in surface expression of
CD8-CIMPR, although not quite as much as clathrin knock-
downs, possibly because knocking down clathrin affects
intracellular trafficking as well as endocytosis. For
instance, the CIMPR has a DXXLL motif, which binds to
GGAs (24), and this motif has been shown to be important
for the sorting of lysosomal enzymes bound to the CIMPR
(25). The YXXF motif is essential for rapid endocytosis of
the CIMPR (26), and consistent with this observation, we
find that AP-2 knockdowns affect the rate of internaliza-
tion of CD8-CIMPR nearly as much as clathrin knock-
downs do.
Much less is known about the trafficking of CPD, and its
abundance in CCVs purified from both placenta and liver
was unexpected. Like the CD8-CPD chimera, endogenous
CPD has been shown to reside mainly in the TGN, but a
fraction of the protein is at the plasmamembranewhere it is
efficiently endocytosed (27). Mutagenesis studies on CPD
suggest that it containsmore than one sorting signal (17,18).
Most prominent is an acidic cluster containing potential
phosphorylation sites for casein kinase II, which is believed
to function by interacting with PACS-1. However, we found
that PACS-1 knockdowns did not affect the steady-state
distribution of CD8-CPD. Other potential sorting signals in
the CPD tail include FHRL, which resembles a YXXF motif,
and two [D/E]XXXL[L/I]-like sequences, DEIRMM and
SKKSLL (17,18). Although the relative importance of these
sequences is not yet known, our results clearly show that
trafficking of the CD8-CPD chimera is clathrin-dependent. In
addition, we find that knocking down AP-1 and AP-2
together produces a strikingly similar phenotype to knocking
down clathrin, indicating that CPD depends on both APs for
its normal steady-state distribution. However, at present,
we cannot say whether AP-1 and AP-2 bind directly or
indirectly to the CPD tail or which of the potential sorting
signals they recognize.
The LRP1 tail is particularly rich in potential sorting signals,
including two NPXY motifs, two [D/E]XXXL[L/I] motifs and
a YXXF motif. Two previous studies led us to suspect that
trafficking of the CD8-LRP1 chimera would be AP-2
dependent. First, Bu and co-workers (14) engineered
mutations into a tagged LRP1 ‘minireceptor’ (i.e. missing
part of the extracellular domain) and came to the
conclusion that the YXXF motif was the most important
sorting signal for endocytosis. Second, Conner and
Schmid (28) used a dominant negative approach to block
AP-2 function and showed that internalization of both
transferrin and RAP (a ligand for LRP1) was inhibited, but
internalization of EGF still proceeded normally. However,
the CD8-LRP1 chimera behaves somewhat differently.
The steady-state distribution and the rate of internalization
of the chimera are both strongly affected by clathrin deple-
tion, but they are affected either very little or not at all by
AP-2 depletion. Interestingly, mutating the tyrosine resi-
due that contributes both to the YXXF motif and to the
second NPXY motif makes the construct much more
dependent upon AP-2. Thus, for reasons that are still not
clear, in the context of a CD8 chimera, the FXNPXY motif
appears to be the dominant sorting signal in the LRP1 tail
rather than the YXXF motif, and the construct can still be
correctly sorted in the absence of any detectable AP-2.
However, a role for AP-2 in the sorting of the CD8-LRP1
chimera is unmasked when a single amino acid substitu-
tion is made, indicating that AP-2 contributes to the sort-
ing of the chimera even though it is not absolutely
required.
Thus, all three of the major glycoproteins that we identi-
fied in our CCV preparations use (or can use) AP com-
plexes for their trafficking. Although this is consistent with
the hypothesis that AP complexes are more abundant
than other adaptors because AP-dependent cargo proteins
are more abundant than AP-independent cargo proteins,
there are two caveats. First, LRP1 may be equally or more
dependent on other adaptors that recognize the FXNPXY
motif. Second, it is clear from the gels shown in Figure 1
that in both placenta and liver CCV preparations, the AP
complexes are in vast molar excess over their cargo pro-
teins; indeed, in order to detect the cargo proteins at all,
we had to use lectin pulldowns of CCV extracts. One
possible explanation for the high abundance of AP com-
plexes relative to cargo is that APs and other adaptors may
function mainly to promote clathrin assembly onto mem-
branes, and cargo binding may be an incidental event;
thus, many of the adaptors would be ‘empty’. However,
a recent live cell-imaging study suggests that in fact cargo
capture may play a key role in CCV formation, stabilizing
nascent clathrin-coated pits and committing them to
become coated vesicles (29). An alternative explanation
is that many of the CCVs in our preparations may them-
selves be empty, without any vesicles inside. Normally,
clathrin and adaptors are thought to assemble only onto
membranes, but during the time it takes to prepare tis-
sues for CCV isolation, there may be anomalous assembly
of some of the soluble clathrin and adaptors into empty
coats [indeed, the abundance of ‘empties’ in CCV prepara-
tions was first remarked upon by Pearse (30)].
Interestingly, in CCV preparations from HeLa cells, which
can be processed more quickly than tissues like placenta
or liver, we find that the CIMPR and transferrin receptor
are among the major bands that are depleted when
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clathrin is knocked down (unpublished observations).
Thus, the cargo to adaptor ratio in CCVs isolated from
placenta and liver may be misleadingly low.
What are the sorting signals on the CIMPR, CPD and
LRP1 that bind to AP complexes and direct them into
CCVs? The CIMPR and LRP1 most likely use YXXF and/
or [D/E]XXXL[L/I] motifs. The CPD tail also contains
sequences that are related to these two motifs; however,
none of them quite fits the consensus sequences. Thus,
further studies will be necessary to determine precisely
how CPD is sorted by AP complexes. It is possible that
CPD – and other cargo proteins as well – may use novel
mechanisms to bind to APs. The precedent of the COPII
complex, which has multiple binding sites on its surface
for different cargo proteins (31), supports the possibility
that there may be additional sorting signals that bind to AP
complexes, which have yet to be characterized.
Materials and Methods
Protein chemistry
Unless otherwise specified, reagents were purchased from Sigma. Clathrin-
coated vesicles were isolated from rat liver using a previously published
method (32) and from human placenta using the method described by
Manfredi and Bazari (33) for brain CCVs, followed by a sucrose step gradient
using the method described by Pilch (32) et al. for liver CCVs. To isolate
membrane glycoproteins, we incubated 100–200 mL of a rat liver or human
placenta CCV sample (approximately 2 mg/mL) or a similar amount of resus-
pended pellet from the first high-speed centrifugation step (i.e. crude mem-
branes) with an equal volume of extraction solution (2 m Tris pH 7.0, 2%
Triton-X-100, 2 mm EDTA, 0.04% NaN3 and 0.2% b-mercaptoethanol) for
60 min at room temperature, then centrifuged in a Beckman TLA 100.2 rotor
at 100,000 g for 15 min at 4 C. The supernatant was diluted with 10
volumes of Buffer A (0.1 M MES, 0.2 mM EGTA, 0.5 mM MgCl2, 0.02%
NaN3 and 0.2 mM AEBSF, pH 6.5) and 25 mL (1:1 v/v) of lectin coupled to
agarose was added and incubated on a rocker at 4 C for 45 min. The lectins
included WGA, concanavalin A, Ricin communis agglutinin I, Dolichos
biflorus agglutinin, peanut agglutinin and soybean agglutinin, all purchased
from Vector Laboratories (Burlingame, CA, USA). The lectin-agarose
together with any bound proteins was then pelleted and washed three
times with cold Buffer A, protein was eluted by boiling in 30 mL of 2
SDS–PAGE sample buffer and the samples were subjected to SDS–PAGE.
Coomassie Blue-stained gel bands were excised, washed, in-gel digested
with trypsin and subjected to MALDI-TOF mass spectrometry (34) using
either a Voyager-DE STR mass spectrometer (Perseptive Biosystems,
League City, TX, USA) or a TofSpec 2E (Micromass UK). Database searches
using peptide masses were performed with the Mascot program (http://
www.matrixscience.com).
Clathrin-coated vesicles were also isolated from HeLa cells, using the
method of Hirst et al. (12). Western blots of whole cell homogenates and
of isolated CCVs were probed with antibodies against EF-2 (Santa Cruz
Biotechnology, Santa Cruz, CA, USA), clathrin heavy chain (35), PACS-1 (a
kind gift from Colin Crump and Gary Thomas, Vollum Institute) and CD8
(Santa Cruz Biotechnology), followed by a rabbit antibody linker if appro-
priate and then by 125I-protein A, as previously described (36).
Construction and localization of the constructs
EST cDNA clones encoding CPD (Clone ID 2303562) and LRP1 (Clone ID
2324562) were obtained from the IMAGE Consortium. Primers were
designed to polymerase chain reaction (PCR) through the region encoding
the cytoplasmic tails of the respective proteins, incorporating an AflII site at
the 5´ end. PCR products were ligated to the AflII site at the end of the
transmembrane domain coding sequence of CD8 in pBluescript (a kind gift
from Gudrun Ihrke, University of Cambridge) (37), and the resulting
chimeras were cloned into pIRESNeo2 (BD Bioscience, Oxford, UK). The
constructs were sequenced to confirm that a correct in-frame fusion had
been achieved, then transfected into HeLa cells. Stably expressing cells
were selected and maintained in the presence of 500 mg/mL G418
(Invitrogen, Paisley, UK). The CD8-expressing and CD8-CIMPR-expressing
HeLa cell lines were generous gifts from Matthew Seaman (Cambridge
Institute for Medical Research, Cambridge, UK) (16). Point mutations were
made using a QuikChange II Site-Directed Mutagenesis Kit (Stratagene
Corporation, La Jolla, CA, USA).
The constructs were localized by immunofluorescence and immunogold
EM. Antibodies used for immunofluorescence included affinity-purified
rabbit anticlathrin heavy chain (35), mouse monoclonal anti-CD8 (Ancell
Corporation, Bayport, MN, USA) and sheep anti-TGN46 (Serotec Inc.,
Oxford, UK). Secondary antibodies were purchased from Molecular
Probes. For some experiments, endosomes were labeled using ligand
uptake assays. Cells were incubated either with rhodamine-conjugated
WGA (Vector Laboratories), diluted 1:5000 for 15 min at 37 C, or with
Texas Red-conjugated EGF (Molecular Probes, Inc.), diluted 1:250 for
30 min at 37 C. Cells were viewed using a Zeiss Axiophot fluorescence
microscope equipped with a CCD camera (Princeton Scientific
Instruments, Monmouth Junction, NJ, USA), and photographs were
recorded using IP Laboratories software and then moved into Adobe
Photoshop. For immunogold localization of the CD8 chimeras, cells were
fixed for 1 h with 4% paraformaldehyde, 0.1% glutaraldehyde, 2% acryline
in 0.1 M sodium cacodylate, pH 7.2, at room temperature, pelleted and
embedded in gelatin. The cells were then prepared for ultrastructural
immunocytochemistry as previously described (36), using rabbit anti-CD8
(a kind gift from Stefano Bonatti, Universita’ di Napoli Federico II, Naples,
Italy) (38) followed by protein A coupled to 15 nm gold. Sections were
observed in a Philips CM100 transmission electron microscope.
Assays for sorting
siRNA knockdowns were carried out as previously described (7,12) using
oligos m2-2 for AP-2, chc2-2 for clathrin heavy chain and m1A for AP-1. Two
new siRNAs were synthesized for PACS-1, with the sequences
GACGAAGAUCUCCGGAAAG (PACS-1 siRNA1) and
AGCAUCCUCAGCACGCCAA (PACS-1 siRNA2). Surface expression of
CD8 chimeras was assayed by binding anti-CD8 (Ancell Corporation), fol-
lowed by 125I-protein A, to cells incubated at 4 C, as previously described
(39). Internalization of prebound antibody-protein A complex was assayed
by warming the cells to 37 C for various lengths of time, then stripping off
surface-bound label by acid washing and quantifying counts in the medium,
associated with the cell surface and inside the cells (7). A flow cytometry-
based assay was also used to monitor internalization of CD8 chimeras.
Cells were incubated with Cy5-labeled monoclonal anti-CD8 (1:20 dilution;
Serotec Inc.) either at 4 C for 45 min or at 37 C for 15 min, then washed,
trypsinized, fixed and analyzed on a FACSCalibur flow cytometer, using FCS
Press software.
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